Country: South Africa
Language: English
Source: South African Health Products Regulatory Authority (SAHPRA)
Abbvie (Pty) Ltd
See ingredients
SUSPENSION
EACH 1 ml SUSPENSION CONTAINS PREDNISOLONE ACETATE 10 mg
Registered
1977-11-12
AbbVie (Pty) Ltd Pred Forte ® Sterile Eye Suspension Prednisolone acetate 10 mg/ml 1.3.2 Patient Information Leaflet Page 1 of 3 PATIENT INFORMATION LEAFLET SCHEDULING STATUS Schedule 4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PRED FORTE STERILE EYE SUSPENSION, PREDNISOLONE ACETATE 10 mg/ml sterile eye suspension READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING PRED FORTE STERILE EYE SUSPENSION Keep this leaflet. You may need to read it again. If you have further questions, please ask your doctor or your pharmacist. PRED FORTE has been prescribed for you personally and you should not share your medicine with other people. It may harm them, even if their symptoms are the same as yours. 1. WHAT PRED FORTE CONTAINS The active substance in PRED FORTE is prednisolone acetate 10 mg/ml. The other ingredients are benzalkonium chloride 0,004 % m/v as a preservative, disodium edetate, hypromellose, sodium chloride, sodium citrate dihydrate, sodium metabisulphite, polysorbate 80 and purified water. 2. WHAT PRED FORTE IS USED FOR PRED FORTE belongs to a group of medicines known as steroids. PRED FORTE is used in adults for the short-term treatment of eye inflammation. 3. BEFORE YOU USE PRED FORTE DO NOT USE PRED FORTE: If you are hypersensitive (allergic) to prednisolone acetate, benzalkonium chloride or any of the other ingredients of PRED FORTE; If you have viral, fungal or bacterial eye infections; If you have a mycobacterial infection or tuberculosis of the eye; If you have injuries to or ulcers on the cornea; AbbVie (Pty) Ltd Pred Forte ® Sterile Eye Suspension Prednisolone acetate 10 mg/ml 1.3.2 Patient Information Leaflet Page 2 of 3 If you have glaucoma; If you have previously had herpes simplex. TAKE SPECIAL CARE WITH PRED FORTE Talk to your doctor before using PRED FORTE if you suffer from, or have in the past suffered from: Eye ulcers or have had a disease or treatment to the eye that caused the tissue of the cornea (the see-through layer coverin Read the complete document
AbbVie (Pty) Ltd Pred Forte ® Sterile Eye Suspension Prednisolone acetate 10 mg/ml 1.3.1.1 Professional Information Page 1 of 3 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM PRED FORTE Sterile Eye Suspension COMPOSITION PRED FORTE Sterile Eye Suspension contains: Prednisolone acetate 10 mg/ml Preservative: Benzalkonium chloride 0,004 % m/v Excipients included in the formulation: Boric acid, disodium edetate, hypromellose, sodium chloride, sodium citrate dihydrate, sodium metabisulphite, polysorbate 80, purified water. PHARMACOLOGICAL CLASSIFICATION A 15.2 Ophthalmic preparations with corticosteroids. PHARMACOLOGICAL ACTION PHARMACODYNAMIC PROPERTIES Prednisolone acetate is a synthetic corticosteroid with anti-inflammatory properties. Prednisolone acetate has, on a weight to weight basis, an anti-inflammatory potency three to five times that of hydrocortisone. PHARMACOKINETIC PROPERTIES The pharmacokinetic profile following topical ocular administration of 1 % prednisolone acetate has been evaluated in human volunteers undergoing cataract surgery; peak concentration of prednisolone in aqueous humour was found to occur within two hours after instillation, and the half-life in aqueous humour was estimated to be approximately 30 minutes. Prednisolone is mainly metabolised in the liver. After intravenous administration of 14C- prednisolone, greater than 90 % of the administered radioactivity was excreted in the urine, and approximately 10 - 30 % of the dose was excreted unchanged in urine. INDICATIONS For steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye globe. AbbVie (Pty) Ltd Pred Forte ® Sterile Eye Suspension Prednisolone acetate 10 mg/ml 1.3.1.1 Professional Information Page 2 of 3 CONTRA-INDICATIONS Acute, untreated purulent ocular infections, superficial herpes simplex (dendritic keratitis), vaccinia, varicella and other viral diseases of the cornea and conjunctiva, mycobacterial infection of the eye, fungal diseases of the ocular Read the complete document